Literature DB >> 19035971

Review article: gastro-oesophageal reflux disease and psychological comorbidity.

I Mizyed1, S S Fass, R Fass.   

Abstract

BACKGROUND: A growing number of studies have shown the impact of psychological comorbidities on gastro-oesophageal reflux disease (GERD) patients' symptom reports and healthcare-seeking behaviour. AIM: To review the reported relationship between GERD and psychological comorbidity.
METHODS: Review of the literature on GERD and psychological comorbidity.
RESULTS: Psychological comorbidity is common among GERD patients and appears to afflict all GERD phenotypes. Sexual and physical abuse is also common in GERD patients. Stress enhances perception of oesophageal acid exposure. Treatment for GERD, especially in those who are not responsive to antireflux treatment, may require further evaluation for psychological comorbidity.
CONCLUSIONS: Psychological comorbidity is very common in GERD patients and is likely to play an important role in response, or failure of response, to proton pump inhibitor treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035971     DOI: 10.1111/j.1365-2036.2008.03883.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Psychological Comorbidity and Chronic Heartburn: Which Is the Chicken and Which Is the Egg?

Authors:  Ronnie Fass; Shira S Fass
Journal:  Dig Dis Sci       Date:  2017-02-15       Impact factor: 3.199

2.  Impact of psychiatric disorders on patient satisfaction after Nissen Fundoplication.

Authors:  Carla N Holcomb; Noah J Switzer; Anahita Jalilvand; Patricia Belle; Monet McNally; Kyle Perry
Journal:  Surg Endosc       Date:  2019-08-13       Impact factor: 4.584

3.  Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease.

Authors:  N Vakil; A Niklasson; H Denison; A Rydén
Journal:  United European Gastroenterol J       Date:  2015-10       Impact factor: 4.623

4.  The Effect of Acute Stress on Esophageal Motility and Gastroesophageal Reflux in Healthy Humans.

Authors:  Hong Sub Lee; Chung Kyun Noh; Kwang Jae Lee
Journal:  J Neurogastroenterol Motil       Date:  2017-01-30       Impact factor: 4.924

5.  Impact of gastrointestinal conditions, restrictive diets and mental health on health-related quality of life: cross-sectional population-based study in Australia.

Authors:  Nigel P Stocks; David Gonzalez-Chica; Phillipa Hay
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

6.  Prevalence of Gastroesophageal Disease and Associated Risk Factors Among the Population in Al-Qunfudah.

Authors:  Mosad M Odah; Ashraf A Ewis; Awad A Alessi; Turki M Alhasani; Ali A Alghanmi; Abdulrahman A Almarhabi; Ibrahim M Almuashi; Ali A Almathami; Hassan O Alfakieh; Fuad M Alkudaysi; Ibrahim A Alnashri; Hassan I Alnashri; Mohammed A Awad; Mohammed S Alammari; Adnan A Alessa
Journal:  Cureus       Date:  2021-12-10

7.  Prevalence and risk factors of gastroesophageal reflux symptoms in a Chinese retiree cohort.

Authors:  Tiantian Chen; Ming Lu; Xiaofeng Wang; Yajun Yang; Juan Zhang; Li Jin; Weimin Ye
Journal:  BMC Gastroenterol       Date:  2012-11-15       Impact factor: 3.067

8.  Gastroesophageal Reflux Disease and overall and Cause-specific Mortality: A Prospective Study of 50000 Individuals.

Authors:  Farhad Islami; Akram Pourshams; Siavosh Nasseri-Moghaddam; Hooman Khademi; Hossein Poutschi; Masoud Khoshnia; Alireza Norouzi; Taghi Amiriani; Amir Ali Sohrabpour; Ali Aliasgari; Elham Jafari; Shahryar Semnani; Christian C Abnet; Paul D Pharaoh; Paul Brennan; Farin Kamangar; Sanford M Dawsey; Paolo Boffetta; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2014-04

9.  Developing a diagnostic understanding of GERD phenotypes through the analysis of levels of mucosal injury, immune activation, and psychological comorbidity.

Authors:  C Zhong; K Liu; K Wang; H Liu; H Su; J Wu; L Duan
Journal:  Dis Esophagus       Date:  2018-10-01       Impact factor: 3.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.